asthma

AstraZeneca halts asthma study in blow to Synairgen
BioPharma Dive
Wed, 10/12/16 - 11:19 pm
AstraZeneca
asthma
Synairgen
clinical trials
AZD9412
Can AstraZeneca plc (ADR) Asthma Drug Hold Up Against Rivals?
Bidness, ETC
Tue, 09/6/16 - 11:19 pm
AstraZeneca
asthma
benralizumab
GSK
Nucala
Teva Pharmaceutical
Cinqair
Trial failure dashes Vectura's hopes for wider use of asthma drug
BioPharma Dive
Wed, 08/31/16 - 09:10 am
Vectura
asthma
clinical trials
Flutiform
Experimental asthma pill from Novartis posts encouraging results
BioPharma Dive
Mon, 08/8/16 - 11:20 am
Novartis
fevipiprant
asthma
GSK enters $230 million licensing deal with Janssen
BioPharma Dive
Thu, 07/28/16 - 01:46 pm
GSK
Janssen
asthma
Beefing up its respiratory pipeline, GlaxoSmithKline bags J&J drug in $230M deal
Endpoints
Wed, 07/27/16 - 09:59 am
GSK
JNJ
CNTO 7160
asthma
Your inhaler’s watching you: drugmakers race for smart devices
Mass Device
Thu, 07/21/16 - 08:57 am
devices
asthma
lung disease
inhalers
GSK
AstraZeneca
Novartis
smart devices
Boston Scientific logs Pa. reimbursement win for Alair asthma treatment
Mass Device
Mon, 06/27/16 - 03:09 pm
Boston Scientific
devices
asthma
Pennsylvania
Alair
AstraZeneca Announces Positive Results from Benralizumab Phase III Program in Severe Asthma
Yahoo
Tue, 05/17/16 - 09:51 am
AstraZeneca
asthma
severe asthma
benralizumab
Teva’s Asthma Segment: What Could Its Boost Revenues in 2016?
Yahoo/Market Realist
Fri, 04/8/16 - 09:42 am
Teva Pharmaceutical
asthma
earnings
FDA approves Teva's biotech drug for severe asthma
Yahoo/Reuters
Wed, 03/23/16 - 04:06 pm
FDA
Teva Pharmaceutical
asthma
Cinqair
GSK's asthma drug Nucala boosted by long-term safety study
BioPharma Dive
Mon, 03/7/16 - 09:54 pm
GSK
asthma
Nucala
AbbVie to Pay $595 Million for Boehringer Immunology Treatments
Bloomberg
Mon, 03/7/16 - 09:33 am
AbbVie
Boehringer Ingelheim
M&A
psoriasis
Crohn’s disease
asthma
Top asthma drug at Roche posts 1 win, 1 flop in identical PhIIIs
Fierce Biotech
Mon, 02/29/16 - 10:30 am
Roche
Genentech
asthma
clinical trials
lebrikizumab
GSK's First Biologic Treatment For Asthma - Nucala Holds Multi-Billion Dollar Potential
Seeking Alpha
Wed, 02/3/16 - 09:01 pm
GSK
biologics
asthma
Nucala
Genentech snags a PhII-ready IL-33 asthma/COPD drug from Amgen
Fierce Biotech
Fri, 01/29/16 - 08:27 pm
Genentech
asthma
COPD
IL-33
Amgen
Mylan Fires a Shot at GlaxoSmithKline
Motley Fool
Wed, 01/13/16 - 09:49 am
Mylan Labs
GSK
generics
Advair Diskus
asthma
Nephron recalls more than 80,000 cartons of its asthma products
Fierce Pharma
Thu, 12/17/15 - 09:38 am
Nephron
recalls
asthma
Asthmanefrin Racepinephrine
FDA Advisory Committee Recommends Approval of Teva’s Asthma Biologic Reslizumab
Yahoo
Thu, 12/10/15 - 11:18 am
Teva Pharmaceutical
FDA
advisory panels
reslizumab
asthma
Teva’s Phase III Clinical Trial: Reslizumab Helps Lung Function
Yahoo/Market Realist
Wed, 12/2/15 - 05:49 pm
FDA
Teva Pharmaceuticals
reslizumab
asthma

Pages